Mechanisms of type-I- and type-II-interferon-mediated signalling - PubMed (original) (raw)

Review

doi: 10.1038/nri1604.

Affiliations

• PMID: 15864272
• DOI: 10.1038/nri1604

Review

Mechanisms of type-I- and type-II-interferon-mediated signalling

Leonidas C Platanias. Nat Rev Immunol. 2005 May.

Abstract

Interferons are cytokines that have antiviral, antiproliferative and immunomodulatory effects. Because of these important properties, in the past two decades, major research efforts have been undertaken to understand the signalling mechanisms through which these cytokines induce their effects. Since the original discovery of the classical JAK (Janus activated kinase)-STAT (signal transducer and activator of transcription) pathway of signalling, it has become clear that the coordination and cooperation of multiple distinct signalling cascades - including the mitogen-activated protein kinase p38 cascade and the phosphatidylinositol 3-kinase cascade - are required for the generation of responses to interferons. It is anticipated that an increased understanding of the contributions of these recently identified pathways will advance our current thinking about how interferons work.

PubMed Disclaimer

Similar articles

• Mechanisms of type I interferon signaling in normal and malignant cells.
  Li Y, Srivastava KK, Platanias LC. Li Y, et al. Arch Immunol Ther Exp (Warsz). 2004 May-Jun;52(3):156-63. Arch Immunol Ther Exp (Warsz). 2004. PMID: 15247882 Review.
• Mechanisms of Type I interferon cell signaling and STAT-mediated transcriptional responses.
  Lau JF, Horvath CM. Lau JF, et al. Mt Sinai J Med. 2002 May;69(3):156-68. Mt Sinai J Med. 2002. PMID: 12035075 Review.
• Growth hormone-induced production of cytokines in murine peritoneal macrophages in vitro: role of JAK/STAT, PI3K, PKC and MAP kinases.
  Tripathi A, Sodhi A. Tripathi A, et al. Immunobiology. 2009;214(6):430-40. doi: 10.1016/j.imbio.2008.11.013. Epub 2009 Feb 27. Immunobiology. 2009. PMID: 19250698
• Complex modulation of cell type-specific signaling in response to type I interferons.
  van Boxel-Dezaire AH, Rani MR, Stark GR. van Boxel-Dezaire AH, et al. Immunity. 2006 Sep;25(3):361-72. doi: 10.1016/j.immuni.2006.08.014. Immunity. 2006. PMID: 16979568 Review.
• Identification of JAK/STAT signalling components by genome-wide RNA interference.
  Müller P, Kuttenkeuler D, Gesellchen V, Zeidler MP, Boutros M. Müller P, et al. Nature. 2005 Aug 11;436(7052):871-5. doi: 10.1038/nature03869. Nature. 2005. PMID: 16094372

Cited by

• Expression of interferon-stimulated genes, but not polymorphisms in the interferon α/β receptor 2 gene, is associated with coronavirus disease 2019 mortality.
  Hamidah B, Pakpahan C, Wulandari L, Tinduh D, Wibawa T, Prakoeswa CRS, Oceandy D. Hamidah B, et al. Heliyon. 2024 Oct 5;10(19):e39002. doi: 10.1016/j.heliyon.2024.e39002. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39435115 Free PMC article.
• A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis.
  Dey B, Dey RJ, Cheung LS, Pokkali S, Guo H, Lee JH, Bishai WR. Dey B, et al. Nat Med. 2015 Apr;21(4):401-6. doi: 10.1038/nm.3813. Epub 2015 Mar 2. Nat Med. 2015. PMID: 25730264 Free PMC article.
• Identification of novel interferon responsive protein partners of human leukocyte antigen A (HLA-A) using cross-linking mass spectrometry (CLMS) approach.
  Singh A, Padariya M, Faktor J, Kote S, Mikac S, Dziadosz A, Lam TW, Brydon J, Wear MA, Ball KL, Hupp T, Sznarkowska A, Vojtesek B, Kalathiya U. Singh A, et al. Sci Rep. 2022 Nov 12;12(1):19422. doi: 10.1038/s41598-022-21393-z. Sci Rep. 2022. PMID: 36371414 Free PMC article.
• Interferon-stimulated gene 15 as a general marker for acute and chronic neuronal injuries.
  Wang RG, Kaul M, Zhang DX. Wang RG, et al. Sheng Li Xue Bao. 2012 Oct 25;64(5):577-83. Sheng Li Xue Bao. 2012. PMID: 23090498 Free PMC article.
• Germline SAMD9L truncation variants trigger global translational repression.
  Allenspach EJ, Soveg F, Finn LS, So L, Gorman JA, Rosen ABI, Skoda-Smith S, Wheeler MM, Barrow KA, Rich LM, Debley JS, Bamshad MJ, Nickerson DA, Savan R, Torgerson TR, Rawlings DJ. Allenspach EJ, et al. J Exp Med. 2021 May 3;218(5):e20201195. doi: 10.1084/jem.20201195. J Exp Med. 2021. PMID: 33724365 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc

• Miscellaneous

  • NCI CPTAC Assay Portal